Access brought to you by: LOCKSS

Rheumatology Clinical Trials

The Risk of Lymphoma in Patients Receiving Anti-TNF Therapy for RA: Results from the BSR Biologics Register
Head-to-Head Biologics Trial Shows No Difference between Abatacept and Adalimumab
Etanercept Proves Clinically Superior to Discontinuation: Results from the DOSERA Trial
IMPROVED: Final Study Results of Combination Treatment in Patients with Early RA and UA
Short- and Long-Term Efficacy of Tofacitinib in the Treatment of Patients with RA and an Inadequate Response to TNF Inhibitors
SC Tocilizumab Reduces RA Disease Activity When Used with DMARDs
Apremilastin Patients with Psoriatic Arthritis: Results of the PALACE-1 Trial
Efficacy of Different Doses of Rituximab for the Treatment of RA: Data from the CERERRA Collaboration
2-Year Results from the GO-RAISE Trial
Inflammation and Fatty Degeneration in New Bone Formation in Patients with AS Treated with Anti-TNF Agents

Pages